DWA
GILD icon

Delos Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Delos Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77K Buy
+14
New +$1.84K ﹤0.01% 277
2025
Q3 		– Sell
-30
Closed -$3.33K – 298
2025
Q2 		$3.33K Buy
+30
New +$3.19K ﹤0.01% 217
2025
Q1 		– Sell
-30
Closed -$2.77K – 103
2024
Q4 		$2.77K Buy
+30
New +$2.7K ﹤0.01% 158

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Delos Wealth Advisors's GILD Position: Q2 2026 in Review

Delos Wealth Advisors opened a new position in Gilead Sciences (GILD) in Q2 2026: 14 shares worth $1.77K. The stake represents ﹤0.01% of the portfolio and ranks #277 among its holdings. This is a return to the name: Delos Wealth Advisors previously reported a position in GILD as recently as Q2 2025.

Delos Wealth Advisors first reported a position in GILD in Q4 2024 and has held it in 3 quarters since. The position peaked at $3.33K in Q2 2025. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Delos Wealth Advisors held 14 shares of Gilead Sciences worth $1.77K as of Q2 2026.
  • Gilead Sciences was a new Delos Wealth Advisors position in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Delos Wealth Advisors's portfolio in Q2 2026, its #277 holding.
  • Delos Wealth Advisors first reported a position in Gilead Sciences in Q4 2024 and has held it in 3 quarters since.
  • Delos Wealth Advisors's Gilead Sciences position peaked at $3.33K in Q2 2025.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Delos Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.